Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RT
BackgroundOur previous study developed a novel peptide-based vaccine, MP3RT, to fight against tuberculosis (TB) infection in a mouse model. However, the consistency between the immunoinformatics predictions and the results of real-world animal experiments on the MP3RT vaccine remains unclear.MethodI...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2022.1047306/full |
_version_ | 1811255528946401280 |
---|---|
author | Peng Cheng Peng Cheng Yong Xue Jie Wang Zaixing Jia Zaixing Jia Liang Wang Wenping Gong |
author_facet | Peng Cheng Peng Cheng Yong Xue Jie Wang Zaixing Jia Zaixing Jia Liang Wang Wenping Gong |
author_sort | Peng Cheng |
collection | DOAJ |
description | BackgroundOur previous study developed a novel peptide-based vaccine, MP3RT, to fight against tuberculosis (TB) infection in a mouse model. However, the consistency between the immunoinformatics predictions and the results of real-world animal experiments on the MP3RT vaccine remains unclear.MethodIn this study, we predicted the antigenicity, immunogenicity, physicochemical parameters, secondary structure, and tertiary structure of MP3RT using bioinformatics technologies. The immune response properties of the MP3RT vaccine were then predicted using the C-ImmSim server. Finally, humanized mice were used to verify the characteristics of the humoral and cellular immune responses induced by the MP3RT vaccine.ResultsMP3RT is a non-toxic and non-allergenic vaccine with an antigenicity index of 0.88 and an immunogenicity index of 0.61, respectively. Our results showed that the MP3RT vaccine contained 53.36% α-helix in the secondary structure, and the favored region accounted for 98.22% in the optimized tertiary structure. The binding affinities of the MP3RT vaccine to the human leukocyte antigen (HLA)-DRB1*01:01 allele, toll-like receptor-2 (TLR-2), and TLR-4 receptors were -1234.1 kcal/mol, -1066.4 kcal/mol, and -1250.4 kcal/mol, respectively. The results of the C-ImmSim server showed that the MP3RT vaccine could stimulate T and B cells to produce immune responses, such as high levels of IgM and IgG antibodies, IFN-γ, TNF-α, and IL-2 cytokines. Results from real-world animal experiments showed that the MP3RT vaccine could stimulate the humanized mice to produce high levels of IgG and IgG2a antibodies and IFN-γ+ T lymphocytes. Furthermore, the levels of IFN-γ, IL-2, and IL-6 cytokines in mice immunized with the MP3RT vaccine were significantly higher than those in the control group.ConclusionMP3RT is a highly antigenic and immunogenic potential vaccine that can effectively induce Th1-type immune responses in silico analysis and animal experiments. This study lays the foundation for evaluating the value of computational tools and immunoinformatic techniques in reverse vaccinology research. |
first_indexed | 2024-04-12T17:26:11Z |
format | Article |
id | doaj.art-4a7212d811b34c29a6974808e912666e |
institution | Directory Open Access Journal |
issn | 2235-2988 |
language | English |
last_indexed | 2024-04-12T17:26:11Z |
publishDate | 2022-11-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Cellular and Infection Microbiology |
spelling | doaj.art-4a7212d811b34c29a6974808e912666e2022-12-22T03:23:18ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882022-11-011210.3389/fcimb.2022.10473061047306Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RTPeng Cheng0Peng Cheng1Yong Xue2Jie Wang3Zaixing Jia4Zaixing Jia5Liang Wang6Wenping Gong7Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing, ChinaHebei North University, Zhangjiakou, Hebei, ChinaTuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing, ChinaTuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing, ChinaTuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing, ChinaCangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Cangzhou, Hebei, ChinaTuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing, ChinaTuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing, ChinaBackgroundOur previous study developed a novel peptide-based vaccine, MP3RT, to fight against tuberculosis (TB) infection in a mouse model. However, the consistency between the immunoinformatics predictions and the results of real-world animal experiments on the MP3RT vaccine remains unclear.MethodIn this study, we predicted the antigenicity, immunogenicity, physicochemical parameters, secondary structure, and tertiary structure of MP3RT using bioinformatics technologies. The immune response properties of the MP3RT vaccine were then predicted using the C-ImmSim server. Finally, humanized mice were used to verify the characteristics of the humoral and cellular immune responses induced by the MP3RT vaccine.ResultsMP3RT is a non-toxic and non-allergenic vaccine with an antigenicity index of 0.88 and an immunogenicity index of 0.61, respectively. Our results showed that the MP3RT vaccine contained 53.36% α-helix in the secondary structure, and the favored region accounted for 98.22% in the optimized tertiary structure. The binding affinities of the MP3RT vaccine to the human leukocyte antigen (HLA)-DRB1*01:01 allele, toll-like receptor-2 (TLR-2), and TLR-4 receptors were -1234.1 kcal/mol, -1066.4 kcal/mol, and -1250.4 kcal/mol, respectively. The results of the C-ImmSim server showed that the MP3RT vaccine could stimulate T and B cells to produce immune responses, such as high levels of IgM and IgG antibodies, IFN-γ, TNF-α, and IL-2 cytokines. Results from real-world animal experiments showed that the MP3RT vaccine could stimulate the humanized mice to produce high levels of IgG and IgG2a antibodies and IFN-γ+ T lymphocytes. Furthermore, the levels of IFN-γ, IL-2, and IL-6 cytokines in mice immunized with the MP3RT vaccine were significantly higher than those in the control group.ConclusionMP3RT is a highly antigenic and immunogenic potential vaccine that can effectively induce Th1-type immune responses in silico analysis and animal experiments. This study lays the foundation for evaluating the value of computational tools and immunoinformatic techniques in reverse vaccinology research.https://www.frontiersin.org/articles/10.3389/fcimb.2022.1047306/fulltuberculosis (TB)vaccineMP3RTimmune responsescomputational toolsimmunoinformatics |
spellingShingle | Peng Cheng Peng Cheng Yong Xue Jie Wang Zaixing Jia Zaixing Jia Liang Wang Wenping Gong Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RT Frontiers in Cellular and Infection Microbiology tuberculosis (TB) vaccine MP3RT immune responses computational tools immunoinformatics |
title | Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RT |
title_full | Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RT |
title_fullStr | Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RT |
title_full_unstemmed | Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RT |
title_short | Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RT |
title_sort | evaluation of the consistence between the results of immunoinformatics predictions and real world animal experiments of a new tuberculosis vaccine mp3rt |
topic | tuberculosis (TB) vaccine MP3RT immune responses computational tools immunoinformatics |
url | https://www.frontiersin.org/articles/10.3389/fcimb.2022.1047306/full |
work_keys_str_mv | AT pengcheng evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt AT pengcheng evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt AT yongxue evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt AT jiewang evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt AT zaixingjia evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt AT zaixingjia evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt AT liangwang evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt AT wenpinggong evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt |